-
Second-leading cancer killer on the rise in young adults
Dr. John Marshall talks with 7 On Your Side WJLA-TV, about Colon Cancer on the rise in young adults.
Category: News
-
When you have stage 4 cancer, the shutdown is about more than a missed paycheck
A federal employee with colon cancer grapples with complicated insurance problems as a result of the partial government shutdown.
Category: News
-
Genomic and Transcriptomic Profiling Finds Potential Predictors and Therapeutic Targets in Pancreatic Cancer
Dr. Michael Pishvaian’s talk on the prognostic value of HR-DDR mutations in Pancreatic Cancer from ASCO GI is highlighted in ASCO Daily News.
Category: News
-
Immunotherapy Could Have Role in Frontline HCC
In the search to establish new therapeutic options for patients with advanced hepatocellular carcinoma (HCC), immunotherapy has become a frontrunner in many clinical trials in the first-line setting, according to Michael J. Pishvaian, MD, PhD.
Category: News
-
Looking for Zebras in Metastatic Colorectal Cancer
Although colorectal cancer is one of the most commonly diagnosed cancers in the United States,1 and researchers’ understanding of the biology and pathophysiology of CRC has grown, its many variations require that each case be diagnosed with care.
Category: News
-
Ruesch Center and OncLive Recognize Former VP Biden at the Luminary Awards
Former Vice President Joe Biden was among those who were recognized for improving the lives of patients with gastrointestinal cancer at the Second Annual Luminary Awards, hosted by the Ruesch Center and OncLive.
Category: News
-
Discussing Drug Development & Complexity in Clinical Trials at the 9th Annual Ruesch Symposium
At a panel discussion on innovation and challenges in clinical research, panelist discussed difficulties related to planning clinical trials for patients with rare tumor types within the existing paradigm.
Category: News
-
OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancers Honored the 2018 Honorees of the Second Annual Luminary Awards in GI Cancers
OncLive® and The Ruesch Center, the founding partners of the Luminary Awards in GI Cancers, congratulate the 2018 honorees recognized at the Second Annual Luminary Awards ceremony, which was held Thursday, Nov. 29 in Washington, D.C.
Category: News
-
Marshall Explains Recent Trial Data in Terms of the Evolving Landscape of Pancreatic Cancer
During a Targeted Oncology case-based peer perspectives program, John Marshall, MD, reviewed his clinical considerations for the management of pancreatic cancer.
Category: News
-
Luminary Awards in GI Cancers Honor Distinguished Leaders
At the 2nd Annual Luminary Awards, hosted by OncLive and The Ruesch Center for the Cure of Gastrointestinal Cancers, several individuals in the cancer care community were honored for their efforts in improving the lives of patients with gastrointestinal cancers.
Category: News